Dr. Louis Eichel

Dr. Louis Eichel
Dr. Eichel is a graduate of the University of Rochester School of Medicine and Dentistry where he also completed his urology residency. Dr. Eichel also completed 2 years of fellowship training in laparoscopy, endourology, and robotic surgery at the University of California, Irvine. Currently Dr. Eichel serves as chief of the division of urology and director of the laser center for Rochester General Hospital. Dr. Eichel has published numerous book chapters and peer reviewed journal articles pertaining to laparoscopic and robotic surgery. He has taught numerous post graduate courses on advanced endourology and minimally invasive urologic surgery and has been the recipient of numerous teaching and academic awards. Dr. Eichel is certified by the American Board of Urology and serves as an expert reviewer for Urologic Oncology, The Journal of Endourology and Journal of the Society of Laparoendoscopic Surgeons. Locally Dr. Eichel appears regularly as a lecturer and supporter for Us Too Rochester as well as Camp Good Days.
Medical School:

University of Rochester

Residency:

University of Rochester

Fellowship:

University of California, Irvine

Undergraduate:

University of Rochester

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only